Items to consider before adding molecular testing

September 30, 2019

In addition to our billing audits and practice management services, Vachette is now offering assistance in establishing molecular/genetic and toxicology testing services to potentially create new revenue streams for your lab. Many labs are adding these tests to diversify revenue, increase testing volume, and ultimately make more money. But does this make sense for your lab?

Here are a few initial items to consider:

What is the desired scope of testing?

  • Inherited Disease (CGX)
  • Pharmacogenomics (PGX)
  • Oncology (Hematologic/Solid Tumor)
  • Infectious Disease, UTI, Tox, Wound Care

What MAC are you submitting to?

  • Palmetto
  • WPS
  • Noridian
  • Novitas

What technology/platform are you using?

  • Illumina
  • Ion Torrent
  • BD Max
  • Film Array EZ (Biofire)

Are you enrolled in a pre-auth program?

  • MolDX
  • UHC/Beacon
  • EviCore

Want to learn more? Download the free slides from our recent webinar on molecular and genetic testing using the form below:

At Vachette, We address and work with labs and their billers to ensure that services are documented to support billing, claims are going out as they should and, most importantly, your group is getting paid for what is billed. Ready to discuss the steps necessary to add these new services to your testing slate? Give us a call today at 517-486-4262.

Who's reviewing revenue strategy with you at this time?

Are you billing all the correct CPT codes? You’d be surprised at what you might be missing. We will review your Fee Schedule/Charge Master at no cost.

That’s right. For free.

Share This